Type 2 Diabetes Mellitus: Specifically for patients with high fasting and post-meal blood sugar. Insulin Resistance: For patients whose bodies produce insulin but cannot use it effectively. HbA1c Reduction: To lower long-term average blood glucose levels.

This combination addresses the "triumvirate" of diabetes issues: Gliclazide (The Booster): It stimulates the beta cells in the pancreas to produce and release more insulin. Metformin (The Gatekeeper): It reduces the amount of glucose produced by the liver and improves the sensitivity of muscles to insulin, allowing them to absorb sugar more effectively. The SR formulation ensures a steady release to minimize stomach upset. Pioglitazone (The Sensitizer): It works deep at the cellular level (PPAR-gamma receptors) to make your fat and muscle cells much more sensitive to the insulin already circulating in your body.

Because this combination is potent, it carries a broader profile of potential side effects: Hypoglycemia: Low blood sugar (caused primarily by Gliclazide). Symptoms include sweating, hunger, and tremors. Weight Gain: Both Gliclazide and Pioglitazone can lead to mild to moderate weight gain. Edema: Pioglitazone can cause fluid retention (swelling), particularly in the ankles or legs. Digestive Issues: Metformin can cause bloating, gas, or a metallic taste. Serious Risks: Long-term Pioglitazone use requires monitoring for bladder health and bone fractures in women.